The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface. Read more about The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.
Structural characterization of a new N-substituted pantothenamide bound to pantothenate kinases from Klebsiella pneumonia and Staphylococcus aureus. Read more about Structural characterization of a new N-substituted pantothenamide bound to pantothenate kinases from Klebsiella pneumonia and Staphylococcus aureus.
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Read more about EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor. Read more about Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts. Read more about Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.
The roles of Jumonji-type oxygenases in human disease. Read more about The roles of Jumonji-type oxygenases in human disease.
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology. Read more about Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
Salvage or recovery of failed targets by in situ proteolysis. Read more about Salvage or recovery of failed targets by in situ proteolysis.
Case study--structural genomics and human protein kinases. Read more about Case study--structural genomics and human protein kinases.